Clinical trial
A Phase I/II Study of Chondrogen Delivered by Intra-Articular Injection…
NCT00225095 · Mesoblast International Sàrl, Industry · Completed
Key facts
| NCT number | NCT00225095 |
|---|---|
| Title | A Phase I/II Study of Chondrogen Delivered by Intra-Articular Injection Following Meniscectomy |
| Official title | A Phase I/II, Randomized, Controlled, Double Blind, Study of Chondrogen - Adult Universal Cell Delivered by Intra-Articular Injection Following Meniscectomy in Patients 18-60 Years |
| Lead sponsor | Mesoblast International Sàrl, Industry |
| Collaborators | University of Southern California Midwest Orthopedics at Rush - Chicago, IL Unlimited Research - San Antonio, TX Triangle Orthopaedic Associates, P.A. Orthopedic Center of Vero Beach - Vero Beach, FL… |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Recovery Following Partial Medial Meniscectomy |
| Intervention type | Drug |
| Interventions | Mesenchymal Stem Cells, Hyaluronan |
| Enrollment | 60 |
| Start date | Sep 1, 2005 |
| Primary completion | Apr 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | Sep 23, 2005 |
| Last update posted | Dec 27, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: